Debate of the Decade: RCTs in the Era of Precision Oncology
How do you design clinical trials in the era of precision oncology? Are prospective randomized controlled trials necessary anymore? Drs. Ray Kurzrock, Vivek Subbiah, and Christopher Booth join Dr. Chadi Nabhan to answer these important questions.
Officials Provide Update on Phase 3 CheckMate-73L Trial in NSCLC
Bemarituzumab Plus mFOLFOX6 Improves PFS, OS Rates in Gastric Cancers
Age, Male Sex Associated With Development of Lupus Nephritis